|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Phenazone (antipyrin) & its derivs. | $15,752,000 | $3,205,000 | $3,854,000 | $4,141,000 | $5,122,000 | $6,613,704 | $9,949,306 |
| Heterocyclic comps. cont. an unfused pyrazole ring (whether or not hydrogen ... | $13,233,000 | $7,964,000 | $15,145,000 | $21,440,000 | $23,533,000 | $14,912,630 | $58,225,585 |
| Hydantoin & its derivs. | $12,455,000 | $11,568,000 | $10,067,000 | $8,828,000 | $13,997,000 | $17,570,301 | $27,908,175 |
| Heterocyclic comps. cont. an unfused imidazole ring (whether or not hydroge ... | $50,290,000 | $57,478,000 | $120,931,000 | $109,387,000 | $61,425,000 | $90,370,063 | $104,534,480 |
| Pyridine & its salts | $3,499,000 | $6,086,000 | $6,415,000 | $3,700,000 | $3,856,000 | $4,324,345 | $4,740,445 |
| Heterocyclic comps. cont. an unfused pyridine ring (whether or not hydrogen ... | $438,694,000 | $641,983,000 | $652,793,000 | $845,851,000 | $900,548,000 | $1,158,410,370 | $1,726,618,487 |
| Heterocyclic comps. cont. a pyrimidine ring (whether or not hydrogenated)/p ... | $460,603,000 | $482,930,000 | $893,766,000 | $772,365,000 | $867,080,000 | $776,940,622 | $1,021,341,887 |
| Melamine | $109,681,000 | $114,390,000 | $126,853,000 | $126,164,000 | $72,158,000 | $90,529,046 | $116,733,801 |
| Heterocyclic comps. cont. an unfused triazine ring (whether or not hydrogen ... | $109,160,000 | $113,851,000 | $145,281,000 | $145,259,000 | $112,549,000 | $135,718,715 | $176,231,280 |
| 6-Hexanelactam (epsilon-caprolactam) | $342,800,000 | $366,482,000 | $433,151,000 | $482,924,000 | $299,677,000 | $429,945,071 | $527,706,402 |
| Lactams (excl. of 2933.71 & 2933.72) | $57,440,000 | $70,093,000 | $100,235,000 | $89,010,000 | $64,491,000 | $46,382,043 | $86,994,229 |
| Total | $1,613,607,000 | $1,876,030,000 | $2,508,491,000 | $2,609,069,000 | $2,424,436,000 | $2,771,716,910 | $3,860,984,077 |
|
|
